The Hidden Cost of Project Misalignment in Biopharma—and 6 Fixes You Can Use Tomorrow
Biopharma teams don’t fail because of science. They fail because cross-functional execution breaks down. Too many priorities. No shared language. Silos. Fire drills. People burning out. Here’s how high-performing biopharma leaders fix it—without more meetings or headcount.
MFA or Bust: Why Biotech Teams Can't Afford to Skip Multi-Factor Authentication
In the biotech world, data isn’t just valuable—it’s vital. Your company’s email inboxes, document portals, financial systems, and communications tools all hold sensitive information tied to your science, your people, and your IP.
And if you’re not using Multi-Factor Authentication (MFA) to protect those systems? — You’re leaving the door wide open.
Leading with Heart: Emotional Intelligence & the Future of Patient-Centered Drug Development
On this World Health Day, we’re reminded that health isn’t just physical; it’s also mental, emotional, and deeply personal. From setting boundaries to nourishing ourselves with good food and good conversation, these practices build the foundation of well-being.
But how do these principles carry over into the biotech world? What does mindfulness, empathy, or emotional awareness have to do with drug development?
As it turns out: everything.
From Molecule to Market: Strategies for Successful Biotech Drug Development
The journey from molecule to market is one of the most complex and resource-intensive processes in the Biotech industry. Developing a new drug requires rigorous scientific validation, regulatory approvals, and strategic program management to navigate the landscape effectively.